Electrical stimulation for early to moderate dry macular degeneration
Part of Eyes & vision clinical trials.
This study tests a device that delivers mild electrical stimulation to the eye to see if it can improve vision in people with early or intermediate dry age-related macular degeneration. It aims to find a safe treatment that may slow down the disease or improve visual function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 50 years or older.
- Diagnosed with early or intermediate dry age-related macular degeneration.
- Vision between 20/30 and 20/200 in the study eye (moderate to moderately severe vision loss).
- No history of certain eye surgeries or treatments (like injections, laser, or vitrectomy).
- No other eye diseases that could affect results, such as diabetic retinopathy or retinal vein occlusion.
- Must agree to use contraception if of childbearing potential.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether shining a special light on the eye, called photobiomodulation, can help people with dry age-related macular degeneration (AMD). If you have dry AMD and are willing to participate, you will receive the light treatment and be monitored.
This early-stage study tests whether a stem-cell–derived transplant to the back of the eye is safe and tolerable in people with dry age-related macular degeneration (AMD). If you qualify, you may receive the transplant and have close follow-up to watch for side effects.
This trial tests a special optical device that may improve vision for people with legally blind dry age-related macular degeneration (AMD). It focuses on improving how well you can see, despite the damage to the center of your retina.
This trial tests a new type of electrical stimulation, called microcurrent therapy, to see if it can help people with a certain form of age-related macular degeneration (AMD) that is not the "wet" kind. The treatment is delivered through an eye patch-like device and may slow vision loss or improve function.
This study tests whether low-level red-light therapy can help people with dry age-related macular degeneration (AMD), a common cause of vision loss in older adults. The therapy is a painless light treatment that you might receive in multiple sessions, and the study aims to see if it can slow or improve vision decline.
This trial tests a new nerve stimulation treatment for people with geographic atrophy, a form of advanced dry age-related macular degeneration. It aims to see if this treatment can help preserve or improve vision.
Hear when a new Dry Age-related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.